DrugDashboards

Tobramycin

Tobramycin · TOBRAMYCIN 3 mg/mL · Solution · Ophthalmic · Preferred Pharmaceuticals Inc.

NDC 68788-4149-05 · 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER · ANDA · View full market →

The short version

23 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for tobramycin (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $1,307.96 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA064052
TE code
AT
Approval date
Nov 29, 1993
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Tobramycin (Solution)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsTOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCTOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
American Health PackagingTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.TOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Bausch & Lomb IncorporatedTOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Chiesi USA, Inc.TOBRAMYCIN 300 mg/4mLJul 15, 2026Sep 2, 2026
Genericus, Inc.TOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Lifestar Pharma LLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Lifestar Pharma LLCTOBRAMYCIN 300 mg/4mLJul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.TOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCTOBRAMYCIN 300 mg/4mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.TOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Pari Respiratory Equipment, Inc.TOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Ritedose Pharmaceuticals, LLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Sandoz IncTOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Sportpharm LLCTOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.TOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.TOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Viatris Specialty LLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.TOBRAMYCIN 3 mg/mLJul 18, 2026Aug 29, 2026
Proficient Rx LPTOBRAMYCIN 3 mg/mLJul 15, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Tobramycin — NDC 68788-4149-05," retrieved September 3, 2026, https://drugdashboards.com/drug/68788414905.

Free to cite with attribution — see how the data is put together.